Leon Eisen PhD

Who they are

Leon Eisen is a Venture Partner at Network VC — founded Oxitone Medical, which built the world's first FDA-cleared wrist pulse oximetry monitor, and created Quantum Business Thinking™, a proprietary methodology aligning business strategy with nature's principles.

Person

Leon Eisen arrived at venture via the inventor's path, not the banker's: he founded Oxitone Medical, which developed the world's first FDA-cleared wrist pulse oximetry monitor, then stayed on as Founder and Executive Chairman before moving into VC. He completed a program at Harvard Business School Online and has been associated with Merantix Capital. Now a Venture Partner at Network VC in Menlo Park, he sits at the intersection of digital health, AI, and early-stage investing. Alongside the employed track he built two distinct platforms: Quantum Business Thinking™, a methodology and brand around aligning business success with nature's principles, and 'Venture Growth with Leon Eisen,' a YouTube podcast channel interviewing unicorn founders and thought leaders. He writes actively on Medium and LinkedIn — his recurring subjects are investor psychology, what VCs see that founders don't, startup fundraising mechanics, and digital health — and he's appeared on The Investor Relations Podcast, the Persimmon Health Podcast, and Ben Gothard's BGTV Podcast. The through-line is a practitioner who crossed from medical-device inventor to investor and now makes his pattern-recognition public.

Network

Leon's visible network skews toward founders he's featured or engaged with publicly. Sophia Alj, Co-Founder & COO of Chari, appeared on his Intelligent Founder podcast. Amy-Renee Hovorka was a guest on Venture Growth with Leon Eisen, discussing measuring and scaling innovation. His BootstrapLabs community membership also places him inside an applied-AI founder and investor network.

Sophia Alj· Co-Founder & COO, Chari
Amy-Renee Hovorka· Guest speaker on Venture Growth podcast (innovation scaling)

How they likely show up

Long tenure at Oxitone Medical as Founder and Executive Chairman → likely patient with long development cycles and comfortable holding conviction through slow-moving regulatory processes.
Hybrid role pattern (founder, executive chairman, venture partner, podcast host, methodology creator simultaneously) → operates across multiple workstreams at once; probably energized by context-switching rather than single-threaded focus.
Active public writer on Medium and LinkedIn covering investor psychology and VC decision-making → comfortable making his thinking visible and likely expects the same intellectual openness from others.
Built a YouTube podcast channel interviewing unicorn founders → learns by conversation, not just by reading; peer exchange is a deliberate practice for him.
Invented a physical medical device that cleared FDA → grounds abstract strategy in concrete, measurable outcomes; likely skeptical of ideas that can't be validated.
Created and brands Quantum Business Thinking™ as a named methodology → thinks in frameworks and probably enjoys distilling complex dynamics into teachable models.

Conversation tips

→ Ask about the regulatory journey at Oxitone — FDA clearance for a novel wrist-based oximeter is a long, specific road and he'll have strong opinions about what the process taught him as both an inventor and an investor.
→ Reference a specific Medium post or LinkedIn article rather than just saying you follow his work — he publishes enough that a named piece signals you actually read it.
→ Engage with Quantum Business Thinking™ as a serious framework, not a side curiosity — it's a branded methodology he's built a platform around, and treating it as a throwaway will land badly.
→ He podcasts to learn from founders, so come with your own specific takes rather than deferring to him; he likely values a peer exchange more than an audience.

Toolbox

Openers

Open on the Oxitone FDA clearance — he built the world's first FDA-cleared wrist pulse oximetry monitor, which means he navigated a regulatory process almost no early-stage founder survives; that's a rare credential to lead with.
Reference his Investor Relations Podcast episode 'What Investors See That Founders Don't' — it's a specific, named talk that reveals the frame he brings to every deal, and engaging with it directly shows you've done the work.
Bring up Quantum Business Thinking™ by name and ask what a real application of it looks like in a portfolio company — it's his proprietary framework and he's built a platform around it, so it's both a genuine question and a signal of preparation.

Discovery questions

After founding Oxitone and navigating FDA clearance yourself, what do you now look for — or flag as a warning sign — when a digital health founder pitches you on their regulatory path?
Your Investor Relations Podcast episode focuses on what investors see that founders miss — what's the single most consistent blind spot you encounter in founder pitches right now?
How does Quantum Business Thinking™ actually change the advice you give a portfolio company versus standard strategic frameworks — what does a founder do differently when they apply it?

Avoid

Don't treat his medical-device background as historical context to move past quickly — it's the foundation of his credibility as a health-tech investor, and skipping over it to get to 'VC topics' will signal you haven't understood his arc.

Make it yours